On 22 February 2011, it was reported in the press that the Secretary of State for Health, Andrew Lansley, along with 10 strategic health authorities and 114 primary care trusts, has launched a legal action in the High Court against Reckitt Benckiser. The articles speculate that the action may relate to the OFT’s investigation into abuse of dominance by Reckitt Benckiser regarding its marketing of the heartburn medicine, Gaviscon. On 15 October 2010, the OFT announced that it has reached a settlement with Reckitt Benckiser whereby the company admitted abusing its dominant position and agreed to pay a reduced fine of £10.2 million as part of an early resolution agreement. The abuse involved the removal of Gaviscon Original Liquid from a list of prescription drugs available to NHS patients which made it more difficult for doctors and pharmacists to identify generic alternatives. Click here for more information.